Go to the reading

A question to work through

Was MOTS-c actually tested in people?

Ask who received what, and whether results were published.

A headline may say there is research. The next question is more useful: what did that research do?

The mice received MOTS-c

In Lee and colleagues' 2015 study, mice on a high-fat diet gained less weight and handled sugar better after receiving MOTS-c. A

That result does not establish weight loss or better blood sugar in people.

The human studies often measured it

Published human studies described in the review measured the body's own MOTS-c, rather than testing MOTS-c as a treatment. B

Measuring MOTS-c in blood or muscle does not show whether giving it to someone helps. Ask whether anyone in the study received MOTS-c as treatment.

The completed human study used a changed version

The completed treatment study in people used CB4211, an analogue, meaning a changed version of MOTS-c. C

Its maker reported changes in liver and blood sugar tests, but no medical-journal results were found as of September 30, 2026.

Those reports concern CB4211, rather than MOTS-c itself.

A listed study still needs results

A trial tests a treatment through a study with people. As of September 30, 2026, a MOTS-c study was listed as looking for adults in China to take part. D

ClinicalTrials.gov is a public website for study plans and results. Its MOTS-c study page had no results posted as of September 30, 2026.

Putting a study plan on that website does not show that the treatment works.

What answer would help you?

Ask for a study that matches both the substance and your concern. Ask who took part and how the results became public. Keep those questions together.

Carry this with you

Mouse studies do not show what MOTS-c does in people. Measuring it in blood or muscle does not test it as treatment. Results for a changed substance do not answer that question either.

Now look at the current rules

Source notes for this page

A. Lee and colleagues' mouse study

This paper concerns animal treatment findings.

B. FDA's review of the published work

The FDA review separates measuring the body's own MOTS-c from giving MOTS-c as treatment. A measurement does not show a treatment benefit.

C. Public study record for the CB4211 trial

This study record concerns CB4211, a changed version of MOTS-c. Its maker reported results, but they had not appeared in a medical journal. They do not show what MOTS-c itself does.

D. Public study record for the MOTS-c trial

On September 30, 2026, the MOTS-c study page said it was seeking adults to take part. It showed no results. That record does not tell us whether MOTS-c helps people.